RU2019122566A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019122566A3 RU2019122566A3 RU2019122566A RU2019122566A RU2019122566A3 RU 2019122566 A3 RU2019122566 A3 RU 2019122566A3 RU 2019122566 A RU2019122566 A RU 2019122566A RU 2019122566 A RU2019122566 A RU 2019122566A RU 2019122566 A3 RU2019122566 A3 RU 2019122566A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662437262P | 2016-12-21 | 2016-12-21 | |
| US62/437,262 | 2016-12-21 | ||
| PCT/JP2017/045731 WO2018117153A1 (en) | 2016-12-21 | 2017-12-20 | Crystalline forms of a janus kinase inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019122566A RU2019122566A (ru) | 2021-01-22 |
| RU2019122566A3 true RU2019122566A3 (https=) | 2021-12-22 |
| RU2838992C2 RU2838992C2 (ru) | 2025-04-24 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| CN110325536A (zh) | 2019-10-11 |
| EP3559003A1 (en) | 2019-10-30 |
| RU2019122566A (ru) | 2021-01-22 |
| CA3044771A1 (en) | 2018-06-28 |
| IL267393B1 (en) | 2023-03-01 |
| EP3559003B1 (en) | 2022-08-24 |
| IL267393A (en) | 2019-08-29 |
| IL267393B2 (en) | 2023-07-01 |
| CN121045220A (zh) | 2025-12-02 |
| KR102788829B1 (ko) | 2025-03-31 |
| KR20190092440A (ko) | 2019-08-07 |
| AU2017380213B2 (en) | 2022-01-06 |
| MX2019007462A (es) | 2019-08-29 |
| JP2023024729A (ja) | 2023-02-16 |
| MX386181B (es) | 2025-03-18 |
| AU2017380213A1 (en) | 2019-05-23 |
| ES2926986T3 (es) | 2022-10-31 |
| BR112019012210A2 (pt) | 2019-11-12 |
| JP2024161449A (ja) | 2024-11-19 |
| JP2020502224A (ja) | 2020-01-23 |
| TW201829423A (zh) | 2018-08-16 |
| WO2018117153A1 (en) | 2018-06-28 |
| US20200017527A1 (en) | 2020-01-16 |
| US11339181B2 (en) | 2022-05-24 |
| TWI822666B (zh) | 2023-11-21 |